Zayachkivska Oksana, Bula Nazar, Khyrivska Dzvinka, Gavrilyuk Elena, Wallace John L
Department of Physiology, Lviv National Medical University, 69 Pekarska str., 79010, Lviv, Ukraine,
Inflammopharmacology. 2015 Jun;23(2-3):91-9. doi: 10.1007/s10787-015-0230-7. Epub 2015 Feb 25.
The non-steroid anti-inflammatory drugs (NSAIDs) are among the drugs that can commonly cause injury in the esophagus, such as non-reflux oesophagitis, with important clinical consequences. This injury may be 'silent' and therefore often overlooked. Recently, we established that hydrogen sulfide (H2S) is a critical mediator of esophageal mucosal protection and repair. The aim of the study was to determine the effect of naproxen, the most commonly used NSAIDs, on the oesophagus and oesophagogastric junction and its relation with suppression or stimulation of endogenous H2S synthesis during naproxen-induced oesophageal injury.
Rats were treated with vehicle (control) or naproxen, with or without being subjected to water immersion restricted stress (Takagi et al. Chem Pharm Bul 12:465-472, 1964). Subgroups of rats were pre-treated with an inhibitor of H2S synthesis cystathionine γ-lyase (CSE) or cystathionine β-synthase (CBS), or with the Sodium sulphide (NaHS), which spontaneously generates H2S in solution. Damage of the oesophageal mucosa and oesophagogastric junction was estimated and scored using a histological damage index.
Treatment with naproxen increased the thickness of the corneal and epithelial layers of the oesophagus, as well as producing disorganization of the muscle plate and irregular submucosal oedema. Both injury factors, stress and suppression of H2S synthesis resulted in the development of severe esophagitis and damage to the oesophagogastric junction. The damage was exacerbated by inhibitors of H2S biosynthesis, and attenuated by treatment with NaHS.
Inhibition of endogenous H2S synthesis provides a novel experimental model that can be useful in preclinical studies NSAID-related non-reflux oesophagitis. H2S contributes significantly to mucosal defence in the oesophagus.
非甾体抗炎药(NSAIDs)是常见的可导致食管损伤的药物之一,如非反流性食管炎,具有重要的临床后果。这种损伤可能是“隐性的”,因此常常被忽视。最近,我们证实硫化氢(H2S)是食管黏膜保护和修复的关键介质。本研究的目的是确定最常用的非甾体抗炎药萘普生对食管和食管胃交界处的影响,以及其与萘普生诱导的食管损伤过程中内源性H2S合成的抑制或刺激之间的关系。
大鼠接受载体(对照)或萘普生治疗,有无接受水浸限制应激(Takagi等人,《化学与药学通报》12:465 - 472,1964)。大鼠亚组预先用H2S合成抑制剂胱硫醚γ-裂解酶(CSE)或胱硫醚β-合酶(CBS),或用在溶液中自发产生H2S的硫化钠(NaHS)进行预处理。使用组织学损伤指数评估并记录食管黏膜和食管胃交界处的损伤情况。
萘普生治疗增加了食管角膜层和上皮层的厚度,同时导致肌板紊乱和黏膜下不规则水肿。应激和H2S合成抑制这两个损伤因素均导致严重食管炎的发生和食管胃交界处的损伤。H2S生物合成抑制剂会加剧损伤,而NaHS治疗可减轻损伤。
内源性H2S合成的抑制提供了一种新的实验模型,可用于非甾体抗炎药相关非反流性食管炎的临床前研究。H2S对食管黏膜防御有显著贡献。